Morgan Stanley Bio Techne Corp Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Bio Techne Corp stock. As of the latest transaction made, Morgan Stanley holds 5,719,540 shares of TECH stock, worth $283 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,719,540
Previous 4,758,525
20.2%
Holding current value
$283 Million
Previous $343 Million
2.16%
% of portfolio
0.02%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding TECH
# of Institutions
627Shares Held
160MCall Options Held
90KPut Options Held
14.2K-
Vanguard Group Inc Valley Forge, PA18.5MShares$917 Million0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$742 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.4MShares$563 Million0.08% of portfolio
-
State Street Corp Boston, MA6.53MShares$323 Million0.02% of portfolio
-
Select Equity Group, L.P. New York, NY5.37MShares$266 Million1.58% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $1.94B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...